Description
P2.02 The value of SOX11 overexpression in the differential diagnosis of mantle cell lymphoma
- You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart
Article: P2.02 The value of SOX11 overexpression in the differential diagnosis of mantle cell lymphoma
€3.03
Related products
-
1 year subscription print edition of the Belgian Journal of Hematology (BJH)
€209.83 Add to cart -
Article: Calendar of events
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
Article: Highlights in digestive oncology
€3.03 Add to cart
Reviews
There are no reviews yet.